Is Molina Healthcare profitable in 2026?

Yes but shrinking fast: FY2025 adjusted EPS fell to $11.03 from $22.65 in 2024, and Molina guided FY2026 adjusted EPS to at least $5.00, an ~80% two-year collapse driven by surging medical costs, per its Feb 5, 2026 earnings release.

Is Molina Healthcare losing Medicaid members?

Yes. Total membership fell to roughly 5 million by mid-2026 from 5.8 million a year earlier, and Georgetown's Center for Children and Families found Molina had the largest percentage Medicaid enrollment decline (5.8%) among the Big Five MCOs as of May 21, 2026.

Could AI replace Molina Healthcare's core business?

No. Molina's core moat is state Medicaid licensure and risk-bearing insurance contracts like its ~$6 billion Florida CMS deal, which AI cannot substitute for. AI is only automating administrative workflows like prior authorization, per July 2026 disclosures, not the insurance-risk function itself.

Is Molina Healthcare being sued?

Yes, a federal securities fraud class action is active in the Central District of California, Case No. 25-cv-09461, covering the Feb 5 to Jul 23, 2025 class period, after Molina's stock dropped 16.84% on a July 24, 2025 guidance-cut disclosure, per KTMC's July 13, 2026 filing summary.

Who is Molina Healthcare's biggest competitor?

Molina competes directly with the other Big Five Medicaid managed-care organizations: UnitedHealth Group, CVS Health/Aetna, Centene, and Elevance Health, all larger and more diversified, per Georgetown CCF's May 21, 2026 analysis of Medicaid managed care.

Why did Molina Healthcare's stock and earnings crash?

Surging medical costs drove a Q4 2025 adjusted loss of $2.75 per share and cut FY2026 adjusted EPS guidance to at least $5.00 from prior expectations near $24.50, alongside a securities fraud class action over concealed cost-trend disclosures, per filings through July 13, 2026.

Insurance companies · United States

Molina Healthcare

molinahealthcare.com ↗

Government-contracted health insurer running Medicaid managed care plans in multiple states.

Losing its protection

Assessed 20 July 2026 · Evidence as of 20 July 2026

The structural protection is eroding.

On the recordSince 20 July 2026 · Checkable from July 22-23, 2026 · Every call on the record Checkpoint: Q2 2026 earnings release and call

The call

Molina holds its state contracts but is losing members faster than its four biggest rivals while earnings and cash cushion shrink at the same time.

Molina Healthcare is a health insurance company that mostly covers poor people on government programs like Medicaid. It is hard for new competitors to enter this business because states have to approve and license insurers, and Molina has been doing this work since 1980, but the big four other insurers (UnitedHealth, CVS Health, Centene, and Elevance) are stealing customers away and can offer more services because they are bigger and diversified. The company's profits have been cut in half over the past two years, membership is dropping faster than its rivals, and it has borrowed a lot of money, so if doctor and hospital costs keep rising or if the company loses big government contracts, it could be forced to cut costs sharply or even struggle to stay independent.

Why

AI pressure: None apparent. AI could help Molina cut claims costs and admin overhead, but it is not a competitive threat to its Medicaid contracts. Could AI do the core job? Unlikely.

Bigger players: UnitedHealth Group, CVS Health (Aetna), Centene, Elevance Health. These four larger, more diversified rivals bid against Molina in the same state Medicaid RFPs and can absorb cost shocks Molina cannot. Could a giant copy it? No, they are blocked.

What protects it. State licensure and long-standing RFP incumbency since 1980 keep new entrants out, but not these four peers.

What would change this call

Molina's Q2 2026 earnings (July 22-23, 2026) show MLR trend and membership count versus Q1's ~5 million. Rising MLR or further membership loss would confirm the erosion is deepening, not stabilizing.
Outcome of state Medicaid RFP renewals/awards through 2026 involving Molina versus Centene, Elevance, CVS/Aetna. Lost RFPs to named rivals would show peer competitors are directly taking Molina's contracts.
Parent cash balance and leverage ratio reported in Q3/Q4 2026 filings relative to the ~$213M and 6.1x EBITDA levels. Continued cash thinning or rising leverage would show balance-sheet strain worsening under the downturn.

Key numbers

Adjusted EPS fell from $22.65 to $11.03 (FY2025)
FY2026 EPS guidance cut to at least $5.00 (2026-02-05)
Debt at 6.1x TTM EBITDA, parent cash ~$213M (2026-07-13)

Named risks

Active federal securities fraud class action over concealed 2025 cost-trend guidance. Severity: high
Elevated leverage at ~6.1x EBITDA with only $213M parent cash as of Jul 13, 2026. Severity: high
Medicaid membership erosion accelerating ahead of Jan 2027 work-requirement rules. Severity: high
Continued medical-cost trend volatility causing repeated guidance cuts. Severity: medium
Exit from MAPD product line signals ongoing Medicare segment underperformance. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
UnitedHealth Group	losing to	Molina had the largest % Medicaid enrollment decline of the Big Five as of May 21, 2026
CVS Health (Aetna)	losing to	Molina remains smallest of Big Five MCOs by scale per Georgetown CCF, May 21, 2026
Centene	contesting	Both compete for same state Medicaid RFPs amid shared enrollment pressure, 2026
Elevance Health	losing to	Elevance has dedicated AI leadership (CAIO); Molina does not, per Creately org analysis, Mar 31, 2026
State Medicaid MCO incumbents generally	gaining on	Won ~$6B Florida CMS Medicaid Kids contract ramping in 2026, per Jul 13, 2026 report

Questions people ask

Is Molina Healthcare profitable in 2026?: Yes but shrinking fast: FY2025 adjusted EPS fell to $11.03 from $22.65 in 2024, and Molina guided FY2026 adjusted EPS to at least $5.00, an ~80% two-year collapse driven by surging medical costs, per its Feb 5, 2026 earnings release.
Is Molina Healthcare losing Medicaid members?: Yes. Total membership fell to roughly 5 million by mid-2026 from 5.8 million a year earlier, and Georgetown's Center for Children and Families found Molina had the largest percentage Medicaid enrollment decline (5.8%) among the Big Five MCOs as of May 21, 2026.
Could AI replace Molina Healthcare's core business?: No. Molina's core moat is state Medicaid licensure and risk-bearing insurance contracts like its ~$6 billion Florida CMS deal, which AI cannot substitute for. AI is only automating administrative workflows like prior authorization, per July 2026 disclosures, not the insurance-risk function itself.
Is Molina Healthcare being sued?: Yes, a federal securities fraud class action is active in the Central District of California, Case No. 25-cv-09461, covering the Feb 5 to Jul 23, 2025 class period, after Molina's stock dropped 16.84% on a July 24, 2025 guidance-cut disclosure, per KTMC's July 13, 2026 filing summary.
Who is Molina Healthcare's biggest competitor?: Molina competes directly with the other Big Five Medicaid managed-care organizations: UnitedHealth Group, CVS Health/Aetna, Centene, and Elevance Health, all larger and more diversified, per Georgetown CCF's May 21, 2026 analysis of Medicaid managed care.
Why did Molina Healthcare's stock and earnings crash?: Surging medical costs drove a Q4 2025 adjusted loss of $2.75 per share and cut FY2026 adjusted EPS guidance to at least $5.00 from prior expectations near $24.50, alongside a securities fraud class action over concealed cost-trend disclosures, per filings through July 13, 2026.

Timeline

2027-01-01Medicaid work-reporting and 6-month redetermination rules under H.R.1 take effect
2026-07-22Q2 2026 earnings release after market close; call held July 23, 2026
2026-07-16S&P announces Molina moves from SmallCap 600 to MidCap 400, effective Jul 22, 2026
2026-07-14Q1 2026 results: adjusted EPS $2.35, revenue $10.80B, down 3.1% YoY
2026-05-21Georgetown CCF finds Molina had largest % Medicaid enrollment decline among Big Five
2026-02-05FY2025 results: revenue $45.4B, adjusted EPS $11.03; FY2026 EPS guided to at least $5.00
2026-01-01CMS-0057 interoperability and prior-authorization federal rule takes effect
2025-07-24Stock falls 16.84% on disclosure of adverse medical-cost trends
2025-02-05Start of securities fraud class action period, Case No. 25-cv-09461

Revision history

20 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Centene Oscar Health Lincoln National